Bastien Gerby

Toulouse, France

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications

Signals from the bone marrow B cell niches shape pre-leukemic fate in a murine model of B cell acute lymphoblastic leukemia.

Signals from the bone marrow B cell niches shape pre-leukemic fate in a murine model of B cell acute lymphoblastic leukemia.

Journal: Oncogene
Published: August 05, 2025

Selumetinib as an Effective Therapy of Histiocytic Sarcoma Evolving From a B-Cell Acute Lymphoblastic Leukaemia.

Selumetinib as an Effective Therapy of Histiocytic Sarcoma Evolving From a B-Cell Acute Lymphoblastic Leukaemia.

Journal: EJHaem
Published: April 29, 2025

The IL7 receptor and the RAG complex are required for the onset of B-cell acute lymphoblastic leukemia.

The IL7 receptor and the RAG complex are required for the onset of B-cell acute lymphoblastic leukemia.

Journal: Blood advances
Published: February 25, 2025

GATA2 mutated allele specific expression is associated with a hyporesponsive state of HSC in GATA2 deficiency syndrome.

GATA2 mutated allele specific expression is associated with a hyporesponsive state of HSC in GATA2 deficiency syndrome.

Journal: Blood cancer journal
Published: December 02, 2024

Modeling the PAX5P80R Mutation Reveals HIF2α Activation as a Common Feature and Therapeutic Target in B-cell Acute Lymphoblastic Leukemia.

Modeling the PAX5P80R Mutation Reveals HIF2α Activation as a Common Feature and Therapeutic Target in B-cell Acute Lymphoblastic Leukemia.

Journal: Cancer research
Published: May 21, 2024

Stem cell-like reprogramming is required for leukemia-initiating activity in B-ALL.

Stem cell-like reprogramming is required for leukemia-initiating activity in B-ALL.

Journal: The Journal of experimental medicine
Published: February 14, 2023

Monoallelic Heb/Tcf12 Deletion Reduces the Requirement for NOTCH1 Hyperactivation in T-Cell Acute Lymphoblastic Leukemia.

Monoallelic Heb/Tcf12 Deletion Reduces the Requirement for NOTCH1 Hyperactivation in T-Cell Acute Lymphoblastic Leukemia.

Journal: Frontiers in immunology
Published: February 01, 2022

Oncogene-Induced Reprogramming in Acute Lymphoblastic Leukemia: Towards Targeted Therapy of Leukemia-Initiating Cells.

Oncogene-Induced Reprogramming in Acute Lymphoblastic Leukemia: Towards Targeted Therapy of Leukemia-Initiating Cells.

Journal: Cancers
Published: October 07, 2021

The CADM1 tumor suppressor gene is a major candidate gene in MDS with deletion of the long arm of chromosome 11.

The CADM1 tumor suppressor gene is a major candidate gene in MDS with deletion of the long arm of chromosome 11.

Journal: Blood advances
Published: May 18, 2021

A targetable cue in T-cell malignancy.

A targetable cue in T-cell malignancy.

Journal: Blood
Published: May 08, 2020

Germline PAX5 mutation predisposes to familial B-cell precursor acute lymphoblastic leukemia.

Germline PAX5 mutation predisposes to familial B-cell precursor acute lymphoblastic leukemia.

Journal: Blood
Published: April 06, 2020

PAX5-ELN oncoprotein promotes multistep B-cell acute lymphoblastic leukemia in mice.

PAX5-ELN oncoprotein promotes multistep B-cell acute lymphoblastic leukemia in mice.

Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: September 28, 2018
Showing 1-12 of 20

Last Updated: 09/26/2026